Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mitapivat versus Placebo for Pyruvate Kinase Deficiency.
Al-Samkari H, Galactéros F, Glenthøj A, Rothman JA, Andres O, Grace RF, Morado-Arias M, Layton DM, Onodera K, Verhovsek M, Barcellini W, Chonat S, Judge MP, Zagadailov E, Xu R, Hawkins P, Beynon V, Gheuens S, van Beers EJ; ACTIVATE Investigators. Al-Samkari H, et al. Among authors: layton dm. N Engl J Med. 2022 Apr 14;386(15):1432-1442. doi: 10.1056/NEJMoa2116634. N Engl J Med. 2022. PMID: 35417638 Clinical Trial.
Early-onset reduced bone mineral density in patients with pyruvate kinase deficiency.
Al-Samkari H, Grace RF, Glenthøj A, Andres O, Barcellini W, Galactéros F, Kuo KHM, Layton DM, Morado Arias M, Viprakasit V, Dong Y, Tai F, Hawkins P, Gheuens S, Morales-Arias J, Gilroy KS, Porter JB, van Beers EJ. Al-Samkari H, et al. Among authors: layton dm. Am J Hematol. 2023 Mar;98(3):E57-E60. doi: 10.1002/ajh.26830. Epub 2023 Jan 9. Am J Hematol. 2023. PMID: 36594181 Free article. No abstract available.
Bone mineral density in adult patients with pyruvate kinase deficiency on long-term mitapivat treatment.
Al-Samkari H, Grace RF, Glenthøj A, Andres O, Barcellini W, Galacteros F, Kuo KHM, Layton DM, Morado M, Viprakasit V, Tai F, Urbstonaitis R, Morales J, McGee B, Beers EJV. Al-Samkari H, et al. Among authors: layton dm. Haematologica. 2024 Mar 1;109(3):963-967. doi: 10.3324/haematol.2023.282884. Haematologica. 2024. PMID: 37731369 Free PMC article. No abstract available.
Putting unstable hemoglobins on the map of London.
Bain BJ, Hann A, Layton DM. Bain BJ, et al. Among authors: layton dm. Am J Hematol. 2023 Sep;98(9):1488-1489. doi: 10.1002/ajh.27032. Epub 2023 Jul 25. Am J Hematol. 2023. PMID: 37490578 Free article. No abstract available.
Voxelotor in sickle cell disease.
Bain BJ, Myburgh J, Hann A, Layton DM. Bain BJ, et al. Among authors: layton dm. Am J Hematol. 2022 Jun 1;97(6):830-832. doi: 10.1002/ajh.26549. Epub 2022 Apr 8. Am J Hematol. 2022. PMID: 35349729 Free article. No abstract available.
Whole genome sequences discriminate hereditary hemorrhagic telangiectasia phenotypes by non-HHT deleterious DNA variation.
Joyce KE, Onabanjo E, Brownlow S, Nur F, Olupona K, Fakayode K, Sroya M, Thomas GA, Ferguson T, Redhead J, Millar CM, Cooper N, Layton DM, Boardman-Pretty F, Caulfield MJ; Genomics England Research Consortium; Shovlin CL. Joyce KE, et al. Among authors: layton dm. Blood Adv. 2022 Jul 12;6(13):3956-3969. doi: 10.1182/bloodadvances.2022007136. Blood Adv. 2022. PMID: 35316832 Free PMC article.
108 results